Table 3.
Antibiotic resistance phenotypes of donors and transconjugants of human animals and the environment.
| Sample No. | Source | Species | Donor’s Non-B-lactam Resistance Phenotype |
|---|---|---|---|
| CN1 | Fish | E. cloacae | SXT *, CIP *,CN *,TE * |
| CN2 | Fish | E. cloacae | CIP, SXT, CN, TE |
| CN3 | Fish | E. cloacae | CIP *, SXT *, TE *, CN* |
| CN4 | Fish | E. cloacae | CIP, CN, TE, SXT |
| CN5 | Fish | C. braakii | CIP *, SXT *, CN *, TE * |
| CN6 | Fish | E. coli | CIP, SXT, CN, TE |
| CN7 | Fish | E. coli | CIP, TE |
| CN8 | Fish | K. pneumoniae | CIP *, SXT *, CN *, TE * |
| CN9 | Fish | K. pneumoniae | CIP *, SXT *, CN *, TE * |
| CN10 | Fish | K. pneumoniae | CIP, SXT, CN, TE |
| CN11 | Fish | C. braakii | CIP, SXT, CN, TE * |
| CN12 | Pig | E. coli | CIP *, SXT *, TE * |
| CN13 | Pig | E. coli | TE, CIP, CN |
| CN14 | Pig | E. coli | CIP *, SXT *, TE *, CN * |
| CN15 | Local chicken | E. coli | CIP, SXT, CN, TE |
| CN16 | Local chicken | E. coli | CIP, SXT, CN, TE |
| CN17 | Goat | E. coli | SXT, TE *, CN, CIP * |
| CN18 | Dog | E. coli | SXT |
| CN19 | Dog | E. coli | SXT *, CIP *, TE, CN |
| CN20 | Dog | E. coli | CIP *, SXT *, TE * |
| CN21 | Dog | E. coli | CIP *, SXT *, TE *, CN * |
| CN22 | Dog | E. coli | CIP *, CN *, TE *, SXT * |
| CN23 | Dog | E. coli | SXT, TE, CN, CIP |
| CN24 | Environment | E. coli | SXT *, CIP *, TE * |
| CN25 | Environment | E. coli | SXT, TE, CIP |
| CN26 | Environment | E. coli | CIP *, SXT *, TE* |
| CN27 | Environment | E. coli | CIP * |
| CN28 | Environment | E. coli | CIP *, SXT *, CN *, TE * |
| CN29 | Environment | E. coli | CN, CIP *, SXT *, TE * |
| CN30 | Human | E. coli | TE *, CIP *, CN, SXT * |
| CN31 | Human | E. coli | CIP *, SXT * |
| CN32 | Human | E. coli | SXT *, CIP * |
| CN33 | Human | E. coli | TE *, CN *, CIP *, SXT * |
| CN34 | Human | E. coli | SXT *, TE *, CN *, CIP |
| CN35 | Human | E. coli | CIP *, CN *, SXT *, TE * |
| CN36 | Human | E. coli | CIP *, CN *, SXT *, TE * |
| CN37 | Human | E. coli | CIP *, CN *, SXT *, TE * |
| CN38 | Human | E. coli | SXT *, TE *, CIP*, CN * |
| CN39 | Human | E. coli | SXT, TE, CIP *, CN * |
| CN40 | Human | E. coli | SXT *, TE * |
| CN41 | Human | E. coli | SXT, TE *, CIP *, CN |
| CN42 | Human | E. coli | SXT, CIP, CN, TE |
| CN43 | Human | E. coli | CN *, CIP *, SXT *, TE * |
| CN44 | Human | E. coli | SXT, TE, CIP |
| CN45 | Human | E. coli | SXT, TE, CIP, CN |
| CN46 | Human | E. coli | TE, SXT |
| CN47 | Human | E. coli | SXT *, TE *, CIP, CN |
| CN48 | Human | E. coli | SXT *, TE *, CIP, CN |
| CN49 | Human | E. coli | CIP *, CN *, SXT *, TE * |
| CN50 | Human | E. coli | SXT, TE |
| CN51 | Human | E. coli | CN, CIP, SXT, TE |
* Transferable resistance; SXT: Trimethoprim-sulphamethoxazole, CIP: Ciprofloxacin, TE: tetracycline, CN: Gentamicin.